Wall Street slips heading into holiday
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group (UNH) Following 8-K Filing
December 26, 2017 7:55 AM ESTCantor Fitzgerald reiterated an Overweight rating and $235.00 price target on UnitedHealth Group (NYSE: UNH) following the company's 8-K filing. The filing indicates that the company has "signed a definitive purchase agreement and intends to launch a tender offer for Empresas Banmédica, an initial step toward... More
Celgene (CELG) PT Lowered to $130 at Stifel; 'Revlimid Plus Ritxuan did not Achieve Superiority with Co-Primary Endpoints'
December 22, 2017 8:18 AM ESTStifel lowered its price target on Celgene (NASDAQ: CELG) to $130.00 (from $149.00) while maintaining a Buy rating, following the company's announcement regarding an update of Phase 3 trial Revlimid (Revevance).
Analyst Thomas Shrader notes a cautious outlook on the shares, commenting "that Phase III trial... More
